OpGen, Inc. (OPGN) Reports Q1 Loss Per Share of $5.61

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. BAC
4. DRS
5. GS
6. AVAV
7. ACI
8. UNH
9. ORCL
10. JPM

Go back to OpGen, Inc. (OPGN) Reports Q1 Loss Per Share of $5.61

OpGen Reports First Quarter Financial Results and Provides Business Update

June 17, 2015 4:05 PM EDT

GAITHERSBURG, Md., June 17, 2015 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN), an early commercial-stage molecular testing and bioinformatics company, today reported financial results for the three months ended March 31, 2015. Highlights of the first quarter of 2015 and recent weeks include:

Completing a $17.1 million initial public offering (IPO) of common stock and warrants Strengthening the management team by adding Kevin Krenitsky, M.D. as president and Tim Dec as chief financial officer Launching the... More